Nahhh, it's not about the money! Instead of drugs, whay don't they look to prevention?? Here's why.
Scientists estimate the drug's worldwide market would be worth up to $2 billion in the first year alone. It would also be a financial coup worth hundreds of millions of dollars for Melbourne University because it shares patent rights for the drug through Fibrotech Therapeutics.
Prevention doesn't make $2 billion! That is from an article about a new anti fibrosis drug from the Melbourne Age.. Says it all, doesn't it!
